FIELD: medicine, in particular, ophthalmology.
SUBSTANCE: invention relates to prophylaxis of myopia progressing. Biopolymer in amount of 1 ml is administered through cannula in Tenon's space to posterior eye pole, wherein said biopolymer represents 2 % chitosan ascorbate hydrogel solution having deacetilation ratio of 94-98 %, molecular mass of 100-700 kD, containing per 1 l of solution 200 mg of hyaluronic acid, 2g of chondroitin sulfuric acid, 110-440 mug of cattle serum growth factor, and 50 g of heparin.
EFFECT: effective prophylaxis of myopia progressing; due to improved blood circulation in posterior eye pole and building up of sclera tissue followed by biodegradation of biopolymer.
1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING DEGENERATIVE MYOPIA | 2006 |
|
RU2308952C1 |
| METHOD FOR TREATMENT OF CENTRAL ATHEROSCLEROTIC CHORIORETINOPATHY | 2005 |
|
RU2281775C1 |
| METHOD FOR GLAUCOMA TREATMENT WITH NON-STABILIZED VISUAL FUNCTIONS | 2005 |
|
RU2299732C1 |
| METHOD FOR TREATING OPTIC NERVE ATROPHY CASES | 2006 |
|
RU2309749C1 |
| METHOD FOR TREATMENT OF DIABETIC RETINOPATHY WITH PREPARATION "BOL-KHIT" | 2006 |
|
RU2301675C1 |
| METHOD OF IMPROVEMENT OF VISUAL FUNCTIONS AT PRIMARY OPEN ANGLE GLAUCOMA WITH NORMALISED INTRAOCULAR TENSION | 2007 |
|
RU2351299C1 |
| METHOD OF RETROSCLEROFILLING OF EYES WITH DISPERSED BIOMATERIAL "ALLOPLANT" | 2016 |
|
RU2610211C1 |
| OPHTHALMOLOGICAL MEDICINAL AGENT | 1996 |
|
RU2104679C1 |
| METHOD FOR PREDICTION OF COMPLICATIONS IN PATIENTS SUFFERING PROGRESSIVE MYOPIA | 2010 |
|
RU2432119C1 |
| METHOD FOR SUTURE-FREE SURGICAL TREATMENT OF PROGRESSING MYOPIA | 2002 |
|
RU2218134C1 |
